NHAS
RLYB icon

Novo Holdings A/S’s Rallybio RLYB Stock Holding History

Novo Holdings A/S’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-220,983
Closed -$4.23M – 38
2023
Q4 		$4.23M Sell
220,983
-52,517
-19% -$1.28M 0.26% 33
2023
Q3 		$7.37M Hold
273,500
– – 0.54% 31
2023
Q2 		$12.4M Sell
273,500
-10,264
-4% -$503K 0.96% 28
2023
Q1 		$13M Sell
283,764
-3,237
-1% -$167K 0.86% 33
2022
Q4 		$15.1M Buy
287,001
+208,136
+264% +$12.3M 0.94% 29
2022
Q3 		$9.13M Sell
78,865
-1,763
-2% -$157K 0.44% 39
2022
Q2 		$4.87M Buy
80,628
+26,135
+48% +$1.96M 0.24% 46
2022
Q1 		$3.04M Buy
+54,493
New +$4.51M 0.16% 50

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Novo Holdings A/S's RLYB Position: Q1 2024 in Review

Novo Holdings A/S sold out of Rallybio (RLYB) in Q1 2024, closing a stake of 220,983 shares — an estimated $4.23M sold.

Novo Holdings A/S first reported a position in RLYB in Q1 2022 and held it in 8 quarters. The position peaked at $15.1M in Q4 2022. 62 funds tracked by Wall St. Rank hold RLYB as of Q1 2024.

  • Novo Holdings A/S reported no remaining Rallybio position as of Q1 2024 after selling out during the quarter.
  • Novo Holdings A/S sold 220,983 Rallybio shares in Q1 2024, an estimated $4.23M.
  • Novo Holdings A/S first reported a position in Rallybio in Q1 2022 and held it in 8 quarters.
  • Novo Holdings A/S's Rallybio position peaked at $15.1M in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Rallybio as of Q1 2024.

Based on Novo Holdings A/S's 13F filing for Q1 2024, filed 15 May 2024.